Dr. David A. Brogno, MD

Dr. Brogno practices at Trustees of Columbia University in the City of New York in New York, New York.

Dr. Brogno's NPI, 1457373656, was assigned on July 24, 2006. Dr. Brogno graduated from University Of Michigan Medical School in 1983. Dr. Brogno holds New York license 160631.

Dr. Brogno's primary practice is Trustees of Columbia University in the City of New York, at 630 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 342-5155.

Dr. Brogno's primary practice is Trustees of Columbia University in the City of New York in New York, New York. Dr. Brogno is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Brogno to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brogno practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Brogno's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Brogno is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Brogno's licenses on file in 3 states: New York, New Jersey and Michigan.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Brogno treats.

CMS data shows 1,862 Medicare services from Dr. Brogno across 17 procedure codes in 2024, for 461 Medicare patients. Medicare paid $158,656 for them.

CMS counts 461 Medicare patients who saw Dr. Brogno in 2024. The largest group is 75 to 84, with 191 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brogno's median patient age at 73, with 36% women.

In 2024, Dr. Brogno wrote 2,721 Medicare Part D claims for 431 patients. 82% of them were for generic drugs. CMS names the drug for 2,338 of them, across 37 drugs with 11 or more claims each, at $488,076 in total drug cost. In 2023, CMS named 2,438 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Brogno for performance year 2024, reported through an alternative payment model (APM). Dr. Brogno accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 28 procedures of coronary angioplasty and stenting by Dr. Brogno, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Brogno, published from 2018 to 2022. 2018 was the busiest year, with 2. The most frequent topics are Coronary Angiography and Coronary Vessels. Dr. Brogno's most frequent co-authors are Barry Dean Bertolet, MD, Dean J. Kereiakes, MD and Martin Bert Leon, MD.

CMS Open Payments shows 53 general payments to Dr. Brogno from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $857.

Dmand AI lists 3 awards for Dr. Brogno, most recently Top Doctors: New York Metro Area in 2014.

Dr. Brogno graduated from University Of Michigan Medical School in 1983. Dr. Brogno is a member of ACC and ACP.

Dr. Brogno is in network with 16 carriers, including Elevance, MVP Health Care and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.